CC
Craig A Collard
Chief Executive Officer

Craig A Collard insider trades: Heron Therapeutics (HRTX) stock buys and sales

Chief Executive Officer, Heron Therapeutics Last trade Nov 16, 2023 60 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2009
6
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Craig reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 16, 2023HRTX↑ Buy$138K
Jun 13, 2022OPNT↑ Buy$63K
May 16, 2022OPNT↑ Buy$368K
May 13, 2022OPNT↑ Buy$39K
Nov 24, 2021SRRA↑ Buy$311K
Sep 13, 2021OPNT↑ Buy$45K
Sep 10, 2021OPNT↑ Buy$174K
Apr 3, 2012CRTX↓ Sell$9.0M
Dec 16, 2010CRTX↓ Sell$2.3M
Jul 28, 2009CRTX↓ Sell$6.9M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Craig A Collard's insider trades

Craig A Collard is Chief Executive Officer at Heron Therapeutics (HRTX). Since Jul 28, 2009, Craig has reported 7 open-market purchases worth $1.1M and 3 sales worth $18.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (21 filings), grants and awards (21 filings), shares withheld for taxes (6 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.